Stock Price
14.77
Daily Change
-0.10 -0.67%
Monthly
-8.26%
Yearly
-24.83%
Q1 Forecast
14.69

Adma Biologics reported $83.12M in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
Adma Biologics USD 83.12M 702K Sep/2025
Alnylam Pharmaceuticals USD 1.31B 11.39M Sep/2025
BioCryst Pharmaceuticals USD 828.6M 510K Dec/2024
Minerva Neurosciences USD 0 0 Sep/2024
Novavax USD 233.31M 4.23M Sep/2024
Omeros USD 442.16M 199K Sep/2023
Takeda JPY 4.85T 208B Dec/2025